These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24522299)

  • 1. [Evaluation of the efficacy and safety of tigecycline for treatment of respiratory tract infections: systematic review of literature].
    Moya Cordero P; Ruiz-Aragón J; Molina Linde JM; Márquez-Peláez S; Motiva Sánchez V
    Rev Chilena Infectol; 2013 Dec; 30(6):591-7. PubMed ID: 24522299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia.
    Freire AT; Melnyk V; Kim MJ; Datsenko O; Dzyublik O; Glumcher F; Chuang YC; Maroko RT; Dukart G; Cooper CA; Korth-Bradley JM; Dartois N; Gandjini H;
    Diagn Microbiol Infect Dis; 2010 Oct; 68(2):140-51. PubMed ID: 20846586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia.
    Tanaseanu C; Milutinovic S; Calistru PI; Strausz J; Zolubas M; Chernyak V; Dartois N; Castaing N; Gandjini H; Cooper CA;
    BMC Pulm Med; 2009 Sep; 9():44. PubMed ID: 19740418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The yield of tigecycline in the treatment of community-acquired pneumonia].
    Cilli A
    Tuberk Toraks; 2013; 61(2):155-61. PubMed ID: 23875595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.
    Bergallo C; Jasovich A; Teglia O; Oliva ME; Lentnek A; de Wouters L; Zlocowski JC; Dukart G; Cooper A; Mallick R;
    Diagn Microbiol Infect Dis; 2009 Jan; 63(1):52-61. PubMed ID: 18990531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia.
    Ramirez J; Dartois N; Gandjini H; Yan JL; Korth-Bradley J; McGovern PC
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1756-62. PubMed ID: 23357775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.
    Babinchak T; Ellis-Grosse E; Dartois N; Rose GM; Loh E; ;
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S354-67. PubMed ID: 16080073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections - the European experience.
    Fomin P; Koalov S; Cooper A; Babinchak T; Dartois N; De Vane N; Castaing N; Tellado J;
    J Chemother; 2008 Oct; 20 Suppl 1():12-9. PubMed ID: 19036670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tigecycline: a systematic review of clinical experience during first years of prescription].
    Diomedi P A
    Rev Chilena Infectol; 2009 Apr; 26(2):114-25. PubMed ID: 19621142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tigecycline: a glycylcycline antimicrobial agent.
    Doan TL; Fung HB; Mehta D; Riska PF
    Clin Ther; 2006 Aug; 28(8):1079-1106. PubMed ID: 16982286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tigecycline: in community-acquired pneumonia.
    McKeage K; Keating GM
    Drugs; 2008; 68(18):2633-44. PubMed ID: 19093704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization.
    Falagas ME; Metaxas EI
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):913-23. PubMed ID: 19803699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tigecycline versus levofloxacin for the treatment of community-acquired pneumonia: European experience.
    Dartois N; Castaing N; Gandjini H; Cooper A;
    J Chemother; 2008 Oct; 20 Suppl 1():28-35. PubMed ID: 19036672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Tigecycline for Patients with Hospital-Acquired Pneumonia.
    Xu L; Wang YL; Du S; Chen L; Long LH; Wu Y
    Chemotherapy; 2016; 61(6):323-30. PubMed ID: 27144279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tigecycline: a critical update.
    Shakil S; Akram M; Khan AU
    J Chemother; 2008 Aug; 20(4):411-9. PubMed ID: 18676218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs.
    Shen F; Han Q; Xie D; Fang M; Zeng H; Deng Y
    Int J Infect Dis; 2015 Oct; 39():25-33. PubMed ID: 26283551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of tigecycline monotherapy versus combination therapy for the treatment of hospital-acquired pneumonia (HAP): a meta-analysis of cohort studies.
    Bai XR; Liu JM; Jiang DC; Yan SY
    J Chemother; 2018 May; 30(3):172-178. PubMed ID: 29405898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744].
    Oliva ME; Rekha A; Yellin A; Pasternak J; Campos M; Rose GM; Babinchak T; Ellis-Grosse EJ; Loh E;
    BMC Infect Dis; 2005 Oct; 5():88. PubMed ID: 16236177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.
    Ni W; Li G; Zhao J; Cui J; Wang R; Gao Z; Liu Y
    Infect Dis (Lond); 2018 Jul; 50(7):507-513. PubMed ID: 29316830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.